Results 181 to 190 of about 715,660 (339)

Production of monoclonal antibodies against parainfluenza 3 virus and their use in diagnosis by immunofluorescence [PDF]

, 1985
Joseph L. Waner, Norma J. Whitehurst, Tamyra Downs, Darren GRAVES   +3 more
openalex   +1 more source

Advances in Nano‐Immunomodulatory Systems for the Treatment of Acute Kidney Injury

Advanced Science, EarlyView.
Based on the biodegradability and the immunological reactiveness, IMNs can be broadly classified into four categories. The first category includes types of biologically derived materials that cause immunomodulatory action and biodegradability like nanoparticles of cell membranes, extracellular vesicles, and exosomes.
Chenli Zhang, Zeli Xiang, Pengfei Yang, Ling Zhang, Jun Deng, Xiaohui Liao   +5 more
wiley   +1 more source

Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies. [PDF]

Antibodies (Basel)
Shcherbakov DN, Isaeva AA, Mustaev EA.
europepmc   +1 more source

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

, 1987
Yupin Charoenvit, M F Leef, Leo Yuan, Martha Sedegah, Richard L. Beaudoin   +4 more
openalex   +1 more source

Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses [PDF]

, 1982
Dorreth D. Humphrey, Olen M. Kew, Paul M. Feorino   +2 more
openalex   +1 more source

Monoclonal Antibodies for Immunosuppression

, 1988
Herman Waldmann, Geoffrey Hale, Mike Clark, Steve Cobbold, Richard Benjamin, Peter Friend, Carole Bindon, Martin Dyer, Shixin Qin, Marianne Bruggemann, Helen Tighe   +10 more
openaire   +4 more sources

Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes

Advanced Science, EarlyView.
An integrative approach identifies conserved B‐cell and T‐cell epitopes within SARS‐CoV‐2 proteins, redirecting immune responses from variable to conserved regions. These epitopes elicit robust humoral and cellular immunity, neutralizing diverse viral variants. Promiscuous T‐cell epitopes demonstrate cross‐species efficacy, highlighting their potential
Masaud Shah, Sung Ung Moon, Ji‐Yon Shin, Ji‐Hye Choi, Doyoon Kim, Hyun Goo Woo   +5 more
wiley   +1 more source

Review: An Update on CGRP Monoclonal Antibodies for the Preventive Treatment of Episodic Migraine. [PDF]

Curr Pain Headache Rep
Nicol KS, Burkett JG.
europepmc   +1 more source

Unveiling Structural Heterogeneity and Evolutionary Adaptations of Heteromultimeric Bacterioferritin Nanocages

Advanced Science, EarlyView.
This study explores the structural heterogeneity and evolutionary adaptations of heteromultimeric bacterioferritins. Hetero‐Bfrs, evolved from either a homo‐Bfr or Ftn by gene duplications, differ from homo‐Bfrs substantially in the mechanisms underpinning iron oxidation and reduction despite high similarity in overall structure.
Yingxi Li, Weiwei Wang, Wei Wang, Xing Zhang, Jinghua Chen, Haichun Gao   +5 more
wiley   +1 more source

N-Glycosylation modulators for targeted manipulation of glycosylation for monoclonal antibodies. [PDF]

Appl Microbiol Biotechnol
Gangwar N, Dixit N, Rathore AS.
europepmc   +1 more source